Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SFOSF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$61.7B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $61.70 Billion |
|---|---|
| Enterprise Value | $88.53 Billion |
| Annual dividend | $0.06 |
| Dividend yield | 1.72% |
| Earnings per Share | $1.26 |
| Beta | 0.44 |
| Outstanding Shares | 0 |
Return
| Return on Equity | 10.59% |
|---|---|
| Return on Assets | 4.11% |
| Return on Invested Capital | 5.79% |
Valuation & Multiples
| P/E Ratio | 17.04 |
|---|---|
| PEG | 112.22 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.43 |
| Enterprise Value to EBIT | 17.62 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.46 |
| Debt to Equity | 0.83 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 25, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$1.65 B
Consensus analyst estimateNext Earnings Call
Expected Date
March 29, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$1.66 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
40,603 employees
CEO: Yi Liu
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a comprehensive healthcare enterprise, operating across Mainland China and international markets. Its principal activities include the research, development, production, and commercializ...